PRESS RELEASES
DNA Script Joins GE Research Collaboration to Develop On-Demand Vaccines and Therapeutics in Response to Biothreats for DARPA NOW Project
March 2, 2021DNA Script will receive up to $9.35 Million to leverage the company’s novel enzymatic DNA synthesis (EDS) technology for the …
▶
▶
PRESS RELEASES
DNA Script Presents Data at AGBT Confirming Functional Performance of the Company’s Enzymatic Synthesis (EDS) Technology
March 1, 2021Collaboration with The Jackson Laboratory demonstrates that primers synthesized using enzymatic DNA synthesis (EDS) technology for the ARTIC hCoV-19 amplicon …
▶
▶
PRESS RELEASES
DNA Script Exclusively Licenses baseclick GmbH Technology to Enable Benchtop Printing of Modified DNA On-Demand
February 23, 2021DNA Script, SAS, a leading pioneer in enabling DNA synthesis on demand, and baseclick GmbH announced today an exclusive licensing …
▶
▶
PRESS RELEASES
DNA Script Signs Innovation Development Contract with French Defense Innovation Agency to Enable On-demand Diagnostics Against Emerging Biothreats
January 28, 2021Company will receive $1.6 Million to develop a qPCR probe manufacturing platform to enable the fast detection of highly pathogenic …
▶
▶
AWARDS, PRESS RELEASES
DNA Script Honored by Goldman Sachs for Entrepreneurship
October 14, 2020Sylvain Gariel, COO, Among 100 Most Intriguing Entrepreneurs at 2020 Builders + Innovators Summit DNA Script today announced Goldman Sachs …
▶
▶
PRESS RELEASES
DNA Script Expands Series B to $89M
July 29, 2020DNA Script today announced a $50 million extension to its Series B financing, bringing the total investment of this round …
▶
▶
PRESS RELEASES
DNA Script Presents New Data Demonstrating the Feasibility of the Company’s Enzymatic Synthesis Technology
February 27, 2020DNA Script today announced the presentation of new data in support of the company’s innovative enzymatic DNA synthesis (EDS) technology …
▶
▶
PRESS RELEASES
IARPA Funds Team Involving DNA Script, the Broad Institute, and Harvard University for DNA Data Storage Research and Development
January 15, 2020DNA Script today announced that the company and its Molecular Encoding Consortium partners have been awarded a multi-phase contract worth …
▶
▶
PRESS RELEASES
DNA Script to Open U.S. Office in South San Francisco to Support Commercialization of the Company’s Industry-Leading Enzymatic Synthesis Technology
November 5, 2019DNA Script today announced the acquisition of new office and lab space in South San Francisco, California. As DNA Script …
▶
▶
PRESS RELEASES
DNA Script Raises $38.5 Million in Series B Financing
May 16, 2019DNA Script today announced an oversubscribed Series B fundraising of $38.5M led by LSP, one of Europe’s largest and most …
▶
▶
PRESS RELEASES
DNA Script Announces World’s First Enzymatic Synthesis of a High-Purity 200-Nucleotide Strand of DNA
February 27, 2019Here at the Advances in Genome Biology and Technology (AGBT) General Meeting, DNA Script, the global leader in the development …
▶
▶
PRESS RELEASES
DNA Script Creates U.S. Subsidiary and Expands Executive Team in the U.S.
November 8, 2018DNA Script, the global leader in the development of enzymatic DNA synthesis, today announced the creation of DNA Script Inc., …
▶
▶
PRESS RELEASES
DNA Script Announces World’s First Enzymatic Synthesis of a High-Purity 150-Nucleotide Strand of DNA
October 2, 2018DNA Script, the global leader in the development of enzymatic DNA synthesis, today announced that it has successfully synthesized the …
▶
▶
PRESS RELEASES
DNA Script awarded $2.7M in Innovation Grants From Bpifrance Total Financing Raised to Date Is $27M
July 10, 2018DNA Script announced today it has been awarded $2.7M in non-dilutive financing from the “Concours d’Innovation” program of Bpifrance. DNA …
▶
▶
PRESS RELEASES
DNA Script to Present at the GP-write Scientific Working Meeting
April 27, 2018DNA Script, a leader in the field of enzymatic de novo manufacturing of nucleic acids, today announced that Thomas Ybert, Ph.D, chief …
▶
▶
